This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-301a-3p | ABCA1 | 2.81 | 0 | -0.71 | 0.00276 | miRNATAP | -0.18 | 0 | NA | |
2 | hsa-miR-301a-3p | ABHD2 | 2.81 | 0 | -0.37 | 0.12248 | mirMAP | -0.12 | 0.00066 | NA | |
3 | hsa-miR-301a-3p | ACVR1 | 2.81 | 0 | -0.44 | 0.01143 | MirTarget; miRNATAP | -0.21 | 0 | NA | |
4 | hsa-miR-301a-3p | ACVRL1 | 2.81 | 0 | -1.25 | 0 | mirMAP | -0.28 | 0 | NA | |
5 | hsa-miR-301a-3p | ADAM12 | 2.81 | 0 | 0.88 | 0.05623 | miRNATAP | -0.39 | 0 | NA | |
6 | hsa-miR-301a-3p | ADAMTS18 | 2.81 | 0 | -0.74 | 0.14599 | miRNATAP | -0.32 | 2.0E-5 | NA | |
7 | hsa-miR-301a-3p | ADCY2 | 2.81 | 0 | -3.87 | 0 | miRNATAP | -0.6 | 0 | NA | |
8 | hsa-miR-301a-3p | AGFG1 | 2.81 | 0 | -0.17 | 0.30925 | MirTarget; miRNATAP | -0.12 | 0 | NA | |
9 | hsa-miR-301a-3p | AGPAT4 | 2.81 | 0 | -0.79 | 0.01174 | mirMAP | -0.2 | 2.0E-5 | NA | |
10 | hsa-miR-301a-3p | AKNA | 2.81 | 0 | -0.9 | 2.0E-5 | mirMAP | -0.17 | 0 | NA | |
11 | hsa-miR-301a-3p | ALPK3 | 2.81 | 0 | -1.02 | 0.00049 | mirMAP | -0.21 | 0 | NA | |
12 | hsa-miR-301a-3p | AMOTL1 | 2.81 | 0 | -1.62 | 0 | mirMAP | -0.24 | 0 | NA | |
13 | hsa-miR-301a-3p | APBB2 | 2.81 | 0 | -0.59 | 0.0014 | mirMAP | -0.16 | 0 | NA | |
14 | hsa-miR-301a-3p | APCDD1 | 2.81 | 0 | -1.6 | 0 | MirTarget | -0.14 | 0.00714 | NA | |
15 | hsa-miR-301a-3p | AR | 2.81 | 0 | -3.3 | 0 | mirMAP; miRNATAP | -0.29 | 0.00366 | 25940439 | Mechanism dissection revealed infiltrating pre-adipocytes might function through down-regulation of the androgen receptor AR via modulation of miR-301a and then increase PCa cell invasion via induction of TGF-β1/Smad/MMP9 signals |
16 | hsa-miR-301a-3p | ARHGAP1 | 2.81 | 0 | -0.88 | 0 | MirTarget; miRNATAP | -0.22 | 0 | NA | |
17 | hsa-miR-301a-3p | ARHGAP26 | 2.81 | 0 | -0.72 | 0.00357 | mirMAP | -0.16 | 1.0E-5 | NA | |
18 | hsa-miR-301a-3p | ARL10 | 2.81 | 0 | -1.12 | 0.00198 | mirMAP | -0.25 | 0 | NA | |
19 | hsa-miR-301a-3p | ARRDC3 | 2.81 | 0 | -0.71 | 0.00062 | miRNATAP | -0.13 | 4.0E-5 | NA | |
20 | hsa-miR-301a-3p | ART4 | 2.81 | 0 | -1.65 | 0.00419 | mirMAP | -0.5 | 0 | NA | |
21 | hsa-miR-301a-3p | ASPA | 2.81 | 0 | -4.76 | 0 | mirMAP | -0.48 | 0 | NA | |
22 | hsa-miR-301a-3p | ASXL2 | 2.81 | 0 | -0.51 | 0.09339 | MirTarget; miRNATAP | -0.15 | 0.00099 | NA | |
23 | hsa-miR-301a-3p | ASXL3 | 2.81 | 0 | -3.34 | 0 | mirMAP | -0.3 | 0.00025 | NA | |
24 | hsa-miR-301a-3p | ATXN1 | 2.81 | 0 | -1.51 | 0 | miRNATAP | -0.38 | 0 | NA | |
25 | hsa-miR-301a-3p | B4GALT5 | 2.81 | 0 | -0.51 | 0.00437 | miRNATAP | -0.1 | 0.00011 | NA | |
26 | hsa-miR-301a-3p | BACH2 | 2.81 | 0 | -1.52 | 0.00134 | mirMAP; miRNATAP | -0.51 | 0 | NA | |
27 | hsa-miR-301a-3p | BBX | 2.81 | 0 | -0.51 | 0.00131 | MirTarget; miRNATAP | -0.11 | 0 | NA | |
28 | hsa-miR-301a-3p | BCL9L | 2.81 | 0 | -0.07 | 0.6694 | mirMAP | -0.12 | 1.0E-5 | NA | |
29 | hsa-miR-301a-3p | BEND4 | 2.81 | 0 | -1.97 | 7.0E-5 | mirMAP | -0.24 | 0.00104 | NA | |
30 | hsa-miR-301a-3p | BEND7 | 2.81 | 0 | -0.64 | 0.19325 | mirMAP | -0.15 | 0.04548 | NA | |
31 | hsa-miR-301a-3p | BMP6 | 2.81 | 0 | -0.5 | 0.12985 | MirTarget | -0.22 | 1.0E-5 | NA | |
32 | hsa-miR-301a-3p | BMPR2 | 2.81 | 0 | -0.59 | 4.0E-5 | MirTarget; miRNATAP | -0.19 | 0 | NA | |
33 | hsa-miR-301a-3p | BTG1 | 2.81 | 0 | -0.8 | 2.0E-5 | miRNATAP | -0.15 | 0 | NA | |
34 | hsa-miR-301a-3p | BVES | 2.81 | 0 | -2.76 | 0 | mirMAP | -0.41 | 0 | NA | |
35 | hsa-miR-301a-3p | C15orf52 | 2.81 | 0 | -1.18 | 0.0026 | mirMAP | -0.28 | 0 | NA | |
36 | hsa-miR-301a-3p | C17orf51 | 2.81 | 0 | -0.68 | 0.02254 | mirMAP | -0.15 | 0.00083 | NA | |
37 | hsa-miR-301a-3p | C1S | 2.81 | 0 | -1.94 | 3.0E-5 | MirTarget | -0.65 | 0 | NA | |
38 | hsa-miR-301a-3p | C5 | 2.81 | 0 | -0.99 | 0.00071 | MirTarget | -0.11 | 0.01058 | NA | |
39 | hsa-miR-301a-3p | CADM2 | 2.81 | 0 | -3.84 | 0 | MirTarget; miRNATAP | -0.18 | 0.0416 | NA | |
40 | hsa-miR-301a-3p | CAMK1D | 2.81 | 0 | -0.52 | 0.15669 | mirMAP | -0.21 | 8.0E-5 | NA | |
41 | hsa-miR-301a-3p | CAMK4 | 2.81 | 0 | -1.28 | 0.0022 | mirMAP | -0.3 | 0 | NA | |
42 | hsa-miR-301a-3p | CCDC50 | 2.81 | 0 | -0.78 | 0 | mirMAP | -0.11 | 0 | NA | |
43 | hsa-miR-301a-3p | CCDC6 | 2.81 | 0 | -0.27 | 0.05122 | MirTarget | -0.14 | 0 | NA | |
44 | hsa-miR-301a-3p | CCDC69 | 2.81 | 0 | -2.71 | 0 | mirMAP | -0.42 | 0 | NA | |
45 | hsa-miR-301a-3p | CCDC85A | 2.81 | 0 | -1.95 | 0 | miRNATAP | -0.16 | 0.00541 | NA | |
46 | hsa-miR-301a-3p | CCDC88A | 2.81 | 0 | -0.76 | 0.01199 | miRNATAP | -0.17 | 0.00013 | NA | |
47 | hsa-miR-301a-3p | CCND2 | 2.81 | 0 | -2.43 | 0 | miRNAWalker2 validate | -0.49 | 0 | NA | |
48 | hsa-miR-301a-3p | CCNT1 | 2.81 | 0 | -0.88 | 0.01804 | mirMAP | -0.16 | 0.00504 | NA | |
49 | hsa-miR-301a-3p | CCR6 | 2.81 | 0 | -1.12 | 0.00057 | mirMAP | -0.3 | 0 | NA | |
50 | hsa-miR-301a-3p | CD109 | 2.81 | 0 | -0.51 | 0.31559 | mirMAP | -0.34 | 1.0E-5 | NA | |
51 | hsa-miR-301a-3p | CD69 | 2.81 | 0 | -2.49 | 0 | miRNATAP | -0.5 | 0 | NA | |
52 | hsa-miR-301a-3p | CD99L2 | 2.81 | 0 | -1.2 | 0 | mirMAP | -0.19 | 0 | NA | |
53 | hsa-miR-301a-3p | CDH11 | 2.81 | 0 | -1.4 | 0.00163 | mirMAP | -0.58 | 0 | NA | |
54 | hsa-miR-301a-3p | CDON | 2.81 | 0 | -2.61 | 0 | mirMAP | -0.33 | 0 | NA | |
55 | hsa-miR-301a-3p | CERK | 2.81 | 0 | -1.14 | 9.0E-5 | mirMAP | -0.21 | 0 | NA | |
56 | hsa-miR-301a-3p | CFL2 | 2.81 | 0 | -2.62 | 0 | MirTarget | -0.38 | 0 | NA | |
57 | hsa-miR-301a-3p | CFLAR | 2.81 | 0 | -0.23 | 0.20284 | mirMAP | -0.17 | 0 | NA | |
58 | hsa-miR-301a-3p | CHD5 | 2.81 | 0 | -3.46 | 0 | MirTarget; miRNATAP | -0.17 | 0.01328 | NA | |
59 | hsa-miR-301a-3p | CHD9 | 2.81 | 0 | -0.8 | 1.0E-5 | miRNATAP | -0.15 | 0 | NA | |
60 | hsa-miR-301a-3p | CHST1 | 2.81 | 0 | 0.15 | 0.68777 | MirTarget | -0.25 | 1.0E-5 | NA | |
61 | hsa-miR-301a-3p | CHST11 | 2.81 | 0 | 0.54 | 0.2311 | MirTarget | -0.25 | 0.00014 | NA | |
62 | hsa-miR-301a-3p | CLIP1 | 2.81 | 0 | -0.85 | 0 | MirTarget; miRNATAP | -0.17 | 0 | NA | |
63 | hsa-miR-301a-3p | CLUAP1 | 2.81 | 0 | -0.82 | 3.0E-5 | mirMAP | -0.11 | 0.00012 | NA | |
64 | hsa-miR-301a-3p | CNR2 | 2.81 | 0 | -2.05 | 6.0E-5 | mirMAP | -0.46 | 0 | NA | |
65 | hsa-miR-301a-3p | COL4A4 | 2.81 | 0 | -2.67 | 0 | mirMAP | -0.4 | 0 | NA | |
66 | hsa-miR-301a-3p | CPEB1 | 2.81 | 0 | -4.68 | 0 | MirTarget; miRNATAP | -0.83 | 0 | NA | |
67 | hsa-miR-301a-3p | CPEB3 | 2.81 | 0 | -1.3 | 0 | MirTarget; miRNATAP | -0.16 | 0 | NA | |
68 | hsa-miR-301a-3p | CPEB4 | 2.81 | 0 | -1.56 | 0 | miRNATAP | -0.22 | 0 | NA | |
69 | hsa-miR-301a-3p | CREB5 | 2.81 | 0 | -2.28 | 0 | miRNATAP | -0.42 | 0 | NA | |
70 | hsa-miR-301a-3p | CSF1 | 2.81 | 0 | -1.3 | 0.00033 | MirTarget; miRNATAP | -0.44 | 0 | NA | |
71 | hsa-miR-301a-3p | CTSK | 2.81 | 0 | -1.41 | 0.00081 | MirTarget | -0.52 | 0 | NA | |
72 | hsa-miR-301a-3p | CXCL12 | 2.81 | 0 | -3.26 | 0 | miRNATAP | -0.64 | 0 | NA | |
73 | hsa-miR-301a-3p | CYBRD1 | 2.81 | 0 | -2.55 | 0 | miRNAWalker2 validate | -0.5 | 0 | NA | |
74 | hsa-miR-301a-3p | CYLD | 2.81 | 0 | -0.89 | 0 | miRNATAP | -0.2 | 0 | NA | |
75 | hsa-miR-301a-3p | CYP2U1 | 2.81 | 0 | -1.21 | 0 | MirTarget | -0.16 | 2.0E-5 | NA | |
76 | hsa-miR-301a-3p | DAAM1 | 2.81 | 0 | -0.94 | 0.00028 | MirTarget; miRNATAP | -0.15 | 0.00015 | NA | |
77 | hsa-miR-301a-3p | DENND5B | 2.81 | 0 | -1.35 | 0.0001 | mirMAP | -0.24 | 0 | NA | |
78 | hsa-miR-301a-3p | DLL1 | 2.81 | 0 | -0.9 | 0.01032 | miRNATAP | -0.15 | 0.00507 | NA | |
79 | hsa-miR-301a-3p | DNM3 | 2.81 | 0 | -1.22 | 4.0E-5 | mirMAP | -0.21 | 0 | NA | |
80 | hsa-miR-301a-3p | DPYSL2 | 2.81 | 0 | -1.76 | 0 | MirTarget; miRNATAP | -0.33 | 0 | NA | |
81 | hsa-miR-301a-3p | DSEL | 2.81 | 0 | -1.79 | 0 | MirTarget; miRNATAP | -0.27 | 0 | NA | |
82 | hsa-miR-301a-3p | DTNA | 2.81 | 0 | -4.06 | 0 | mirMAP | -0.64 | 0 | NA | |
83 | hsa-miR-301a-3p | EDN1 | 2.81 | 0 | -0.35 | 0.36497 | MirTarget | -0.25 | 1.0E-5 | NA | |
84 | hsa-miR-301a-3p | EFR3A | 2.81 | 0 | -0.35 | 0.02542 | MirTarget | -0.11 | 0 | NA | |
85 | hsa-miR-301a-3p | ELFN2 | 2.81 | 0 | -0.56 | 0.36612 | mirMAP | -0.34 | 0.00022 | NA | |
86 | hsa-miR-301a-3p | ELK3 | 2.81 | 0 | -0.31 | 0.25641 | MirTarget; miRNATAP | -0.27 | 0 | NA | |
87 | hsa-miR-301a-3p | ELL2 | 2.81 | 0 | -1.08 | 1.0E-5 | MirTarget | -0.2 | 0 | NA | |
88 | hsa-miR-301a-3p | ENDOD1 | 2.81 | 0 | -0.33 | 0.14647 | MirTarget | -0.13 | 6.0E-5 | NA | |
89 | hsa-miR-301a-3p | ESR1 | 2.81 | 0 | -2.87 | 0 | miRNATAP | -0.4 | 0 | NA | |
90 | hsa-miR-301a-3p | FAM126A | 2.81 | 0 | -0.53 | 0.10015 | miRNAWalker2 validate | -0.17 | 0.00035 | NA | |
91 | hsa-miR-301a-3p | FAM129C | 2.81 | 0 | -1.9 | 0.00038 | MirTarget | -0.41 | 0 | NA | |
92 | hsa-miR-301a-3p | FAM155A | 2.81 | 0 | -1.94 | 0 | MirTarget | -0.32 | 0 | NA | |
93 | hsa-miR-301a-3p | FAM46B | 2.81 | 0 | -3.33 | 0 | MirTarget; miRNATAP | -0.54 | 0 | NA | |
94 | hsa-miR-301a-3p | FAM78A | 2.81 | 0 | -0.18 | 0.57167 | MirTarget | -0.26 | 0 | NA | |
95 | hsa-miR-301a-3p | FAT3 | 2.81 | 0 | -2.79 | 0 | MirTarget | -0.36 | 6.0E-5 | NA | |
96 | hsa-miR-301a-3p | FBXW11 | 2.81 | 0 | -0.61 | 0 | MirTarget | -0.1 | 0 | NA | |
97 | hsa-miR-301a-3p | FGFR1 | 2.81 | 0 | -2.88 | 0 | mirMAP | -0.46 | 0 | NA | |
98 | hsa-miR-301a-3p | FIBIN | 2.81 | 0 | -1.93 | 0.00102 | MirTarget | -0.72 | 0 | NA | |
99 | hsa-miR-301a-3p | FMN1 | 2.81 | 0 | -0.37 | 0.4819 | mirMAP | -0.33 | 2.0E-5 | NA | |
100 | hsa-miR-301a-3p | FOSL1 | 2.81 | 0 | -1.55 | 0.00023 | MirTarget | -0.14 | 0.02288 | NA | |
101 | hsa-miR-301a-3p | FOXN3 | 2.81 | 0 | -1.44 | 0 | mirMAP | -0.2 | 0 | NA | |
102 | hsa-miR-301a-3p | FOXO3 | 2.81 | 0 | -0.74 | 0 | mirMAP | -0.14 | 0 | NA | |
103 | hsa-miR-301a-3p | FOXP1 | 2.81 | 0 | -0.87 | 0 | mirMAP | -0.18 | 0 | NA | |
104 | hsa-miR-301a-3p | FRMD6 | 2.81 | 0 | -0.93 | 0.00183 | MirTarget | -0.25 | 0 | NA | |
105 | hsa-miR-301a-3p | FRZB | 2.81 | 0 | -1.17 | 0.00146 | MirTarget | -0.23 | 3.0E-5 | NA | |
106 | hsa-miR-301a-3p | FZD4 | 2.81 | 0 | -0.83 | 0.00068 | mirMAP | -0.12 | 0.00118 | NA | |
107 | hsa-miR-301a-3p | G0S2 | 2.81 | 0 | -1.1 | 0.01873 | MirTarget | -0.33 | 0 | NA | |
108 | hsa-miR-301a-3p | GADD45A | 2.81 | 0 | -0.84 | 0.00014 | MirTarget; miRNATAP | -0.11 | 0.00055 | NA | |
109 | hsa-miR-301a-3p | GALNT13 | 2.81 | 0 | -1.81 | 0.00232 | MirTarget | -0.3 | 0.00058 | NA | |
110 | hsa-miR-301a-3p | GAP43 | 2.81 | 0 | -1.67 | 0.00774 | miRNATAP | -0.39 | 2.0E-5 | NA | |
111 | hsa-miR-301a-3p | GBP4 | 2.81 | 0 | 0.37 | 0.3093 | mirMAP | -0.18 | 0.00098 | NA | |
112 | hsa-miR-301a-3p | GFOD1 | 2.81 | 0 | -0.94 | 0.00661 | mirMAP | -0.34 | 0 | NA | |
113 | hsa-miR-301a-3p | GJA1 | 2.81 | 0 | -1.07 | 0.00282 | MirTarget; miRNATAP | -0.19 | 0.00045 | NA | |
114 | hsa-miR-301a-3p | GPCPD1 | 2.81 | 0 | -0.91 | 0 | miRNATAP | -0.11 | 0.0001 | NA | |
115 | hsa-miR-301a-3p | GPR157 | 2.81 | 0 | -0.17 | 0.63038 | mirMAP | -0.15 | 0.0058 | NA | |
116 | hsa-miR-301a-3p | GPRC5A | 2.81 | 0 | -1.04 | 0.01909 | mirMAP | -0.25 | 0.00019 | NA | |
117 | hsa-miR-301a-3p | GRB10 | 2.81 | 0 | -1.4 | 0 | MirTarget | -0.14 | 0.00118 | NA | |
118 | hsa-miR-301a-3p | GZMK | 2.81 | 0 | -1.65 | 0.00749 | MirTarget | -0.61 | 0 | NA | |
119 | hsa-miR-301a-3p | H6PD | 2.81 | 0 | -0.39 | 0.01374 | mirMAP | -0.11 | 0 | NA | |
120 | hsa-miR-301a-3p | HABP4 | 2.81 | 0 | -1.4 | 0 | MirTarget; miRNATAP | -0.19 | 0 | NA | |
121 | hsa-miR-301a-3p | HCFC2 | 2.81 | 0 | -0.81 | 0 | MirTarget | -0.13 | 0 | NA | |
122 | hsa-miR-301a-3p | HECW2 | 2.81 | 0 | 0.09 | 0.72492 | MirTarget | -0.13 | 0.00062 | NA | |
123 | hsa-miR-301a-3p | HEG1 | 2.81 | 0 | -0.95 | 0.00135 | miRNATAP | -0.37 | 0 | NA | |
124 | hsa-miR-301a-3p | HERC3 | 2.81 | 0 | -0.74 | 0.00166 | MirTarget | -0.17 | 0 | NA | |
125 | hsa-miR-301a-3p | HIPK3 | 2.81 | 0 | -1.75 | 0 | MirTarget | -0.33 | 0 | NA | |
126 | hsa-miR-301a-3p | HIVEP2 | 2.81 | 0 | -0.44 | 0.01281 | miRNATAP | -0.1 | 0.00015 | NA | |
127 | hsa-miR-301a-3p | HRH1 | 2.81 | 0 | -0.42 | 0.09981 | mirMAP | -0.22 | 0 | NA | |
128 | hsa-miR-301a-3p | IDS | 2.81 | 0 | -0.67 | 3.0E-5 | mirMAP | -0.11 | 0 | NA | |
129 | hsa-miR-301a-3p | IGF1 | 2.81 | 0 | -3.76 | 0 | MirTarget | -0.8 | 0 | NA | |
130 | hsa-miR-301a-3p | IL15 | 2.81 | 0 | -0.56 | 0.1044 | MirTarget | -0.19 | 0.00024 | NA | |
131 | hsa-miR-301a-3p | IL17RD | 2.81 | 0 | -1.41 | 2.0E-5 | mirMAP | -0.16 | 0.00083 | NA | |
132 | hsa-miR-301a-3p | IL1RAP | 2.81 | 0 | 0.69 | 0.05618 | MirTarget | -0.15 | 0.00446 | NA | |
133 | hsa-miR-301a-3p | IL6R | 2.81 | 0 | -1.87 | 0 | mirMAP | -0.35 | 0 | NA | |
134 | hsa-miR-301a-3p | IL6ST | 2.81 | 0 | -2.1 | 2.0E-5 | mirMAP; miRNATAP | -0.52 | 0 | NA | |
135 | hsa-miR-301a-3p | INHBB | 2.81 | 0 | -1.64 | 0 | miRNATAP | -0.28 | 0 | NA | |
136 | hsa-miR-301a-3p | IRF1 | 2.81 | 0 | 0.08 | 0.77621 | MirTarget; miRNATAP | -0.14 | 0.00077 | NA | |
137 | hsa-miR-301a-3p | ITGA2 | 2.81 | 0 | 0.78 | 0.03601 | mirMAP | -0.14 | 0.00934 | NA | |
138 | hsa-miR-301a-3p | ITGA8 | 2.81 | 0 | -5.02 | 0 | mirMAP | -0.64 | 0 | NA | |
139 | hsa-miR-301a-3p | ITGB8 | 2.81 | 0 | -0.77 | 0.0782 | MirTarget; miRNATAP | -0.2 | 0.00208 | NA | |
140 | hsa-miR-301a-3p | ITIH5 | 2.81 | 0 | -4.03 | 0 | mirMAP | -0.51 | 0 | NA | |
141 | hsa-miR-301a-3p | ITPR1 | 2.81 | 0 | -2.58 | 0 | MirTarget; miRNATAP | -0.33 | 0 | NA | |
142 | hsa-miR-301a-3p | ITPRIPL2 | 2.81 | 0 | -0.05 | 0.79208 | MirTarget; miRNATAP | -0.15 | 0 | NA | |
143 | hsa-miR-301a-3p | JAKMIP1 | 2.81 | 0 | 0.37 | 0.50423 | MirTarget; miRNATAP | -0.32 | 0.00011 | NA | |
144 | hsa-miR-301a-3p | JAM2 | 2.81 | 0 | -3.24 | 0 | miRNATAP | -0.58 | 0 | NA | |
145 | hsa-miR-301a-3p | JDP2 | 2.81 | 0 | -1.47 | 0 | mirMAP | -0.2 | 0 | NA | |
146 | hsa-miR-301a-3p | JMY | 2.81 | 0 | -0.98 | 0 | MirTarget; miRNATAP | -0.1 | 2.0E-5 | NA | |
147 | hsa-miR-301a-3p | KBTBD8 | 2.81 | 0 | -1.48 | 0 | MirTarget | -0.24 | 0 | NA | |
148 | hsa-miR-301a-3p | KCNAB2 | 2.81 | 0 | -0.72 | 0.01568 | mirMAP | -0.24 | 0 | NA | |
149 | hsa-miR-301a-3p | KCNJ5 | 2.81 | 0 | -0.66 | 0.12278 | mirMAP | -0.31 | 0 | NA | |
150 | hsa-miR-301a-3p | KCTD10 | 2.81 | 0 | -0.83 | 0 | MirTarget | -0.15 | 0 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | REGULATION OF CELL DIFFERENTIATION | 70 | 1492 | 2.753e-16 | 1.281e-12 |
2 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 71 | 1672 | 2.619e-14 | 6.094e-11 |
3 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 71 | 1805 | 1.102e-12 | 1.282e-09 |
4 | NEUROGENESIS | 61 | 1402 | 9.148e-13 | 1.282e-09 |
5 | POSITIVE REGULATION OF GENE EXPRESSION | 68 | 1733 | 4.198e-12 | 3.906e-09 |
6 | CELL DEVELOPMENT | 59 | 1426 | 1.824e-11 | 1.414e-08 |
7 | GROWTH | 29 | 410 | 3.031e-11 | 2.015e-08 |
8 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 48 | 1036 | 4.219e-11 | 2.181e-08 |
9 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 48 | 1036 | 4.219e-11 | 2.181e-08 |
10 | TISSUE DEVELOPMENT | 59 | 1518 | 2.174e-10 | 9.197e-08 |
11 | DEVELOPMENTAL GROWTH | 25 | 333 | 2.12e-10 | 9.197e-08 |
12 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 39 | 771 | 2.839e-10 | 1.101e-07 |
13 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 60 | 1618 | 9.264e-10 | 3.316e-07 |
14 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 53 | 1360 | 1.938e-09 | 6.44e-07 |
15 | REGULATION OF CELL DEVELOPMENT | 39 | 836 | 2.831e-09 | 8.782e-07 |
16 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 66 | 1929 | 3.057e-09 | 8.889e-07 |
17 | ORGAN MORPHOGENESIS | 39 | 841 | 3.342e-09 | 9.149e-07 |
18 | POSITIVE REGULATION OF LOCOMOTION | 26 | 420 | 5.576e-09 | 1.441e-06 |
19 | BLOOD VESSEL MORPHOGENESIS | 24 | 364 | 6.514e-09 | 1.524e-06 |
20 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 55 | 1492 | 6.55e-09 | 1.524e-06 |
21 | SKELETAL SYSTEM DEVELOPMENT | 27 | 455 | 6.912e-09 | 1.532e-06 |
22 | REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 18 | 207 | 7.865e-09 | 1.663e-06 |
23 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 42 | 983 | 8.676e-09 | 1.755e-06 |
24 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 52 | 1395 | 1.26e-08 | 2.272e-06 |
25 | LOCOMOTION | 45 | 1114 | 1.319e-08 | 2.272e-06 |
26 | VASCULATURE DEVELOPMENT | 27 | 469 | 1.309e-08 | 2.272e-06 |
27 | NEGATIVE REGULATION OF CELL COMMUNICATION | 47 | 1192 | 1.274e-08 | 2.272e-06 |
28 | POSITIVE REGULATION OF CELL COMMUNICATION | 55 | 1532 | 1.636e-08 | 2.718e-06 |
29 | CONNECTIVE TISSUE DEVELOPMENT | 17 | 194 | 1.838e-08 | 2.828e-06 |
30 | REGULATION OF CELL PROLIFERATION | 54 | 1496 | 1.884e-08 | 2.828e-06 |
31 | NEGATIVE REGULATION OF CELL PROLIFERATION | 32 | 643 | 1.861e-08 | 2.828e-06 |
32 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 37 | 823 | 1.97e-08 | 2.864e-06 |
33 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 42 | 1021 | 2.556e-08 | 3.604e-06 |
34 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 36 | 801 | 3.136e-08 | 4.291e-06 |
35 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 18 | 229 | 3.79e-08 | 4.899e-06 |
36 | SENSORY ORGAN DEVELOPMENT | 27 | 493 | 3.688e-08 | 4.899e-06 |
37 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 41 | 1004 | 4.663e-08 | 5.863e-06 |
38 | RESPONSE TO MECHANICAL STIMULUS | 17 | 210 | 5.927e-08 | 7.258e-06 |
39 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 44 | 1135 | 6.411e-08 | 7.649e-06 |
40 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 44 | 1142 | 7.638e-08 | 8.885e-06 |
41 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 27 | 513 | 8.302e-08 | 9.422e-06 |
42 | REGULATION OF EPITHELIAL CELL MIGRATION | 15 | 166 | 8.517e-08 | 9.436e-06 |
43 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 56 | 1656 | 9.135e-08 | 9.679e-06 |
44 | NEURON DIFFERENTIATION | 37 | 874 | 9.153e-08 | 9.679e-06 |
45 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 37 | 876 | 9.694e-08 | 1.002e-05 |
46 | REGULATION OF NEURON DIFFERENTIATION | 28 | 554 | 1.1e-07 | 1.112e-05 |
47 | REGULATION OF CELL PROJECTION ORGANIZATION | 28 | 558 | 1.275e-07 | 1.263e-05 |
48 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 46 | 1275 | 2.525e-07 | 2.447e-05 |
49 | RESPONSE TO ENDOGENOUS STIMULUS | 50 | 1450 | 2.803e-07 | 2.661e-05 |
50 | ANGIOGENESIS | 19 | 293 | 3.29e-07 | 3.062e-05 |
51 | REGULATION OF MAPK CASCADE | 30 | 660 | 3.743e-07 | 3.415e-05 |
52 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 39 | 1008 | 4.081e-07 | 3.652e-05 |
53 | REGULATION OF CELL ADHESION | 29 | 629 | 4.423e-07 | 3.883e-05 |
54 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 57 | 1784 | 4.535e-07 | 3.907e-05 |
55 | CELLULAR COMPONENT MORPHOGENESIS | 36 | 900 | 5.423e-07 | 4.588e-05 |
56 | REGULATION OF PROTEIN MODIFICATION PROCESS | 55 | 1710 | 6.092e-07 | 4.887e-05 |
57 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 33 | 788 | 6.081e-07 | 4.887e-05 |
58 | CIRCULATORY SYSTEM DEVELOPMENT | 33 | 788 | 6.081e-07 | 4.887e-05 |
59 | TISSUE MORPHOGENESIS | 26 | 533 | 6.249e-07 | 4.909e-05 |
60 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 58 | 1848 | 6.33e-07 | 4.909e-05 |
61 | REGULATION OF CARTILAGE DEVELOPMENT | 9 | 63 | 7.357e-07 | 5.591e-05 |
62 | POSITIVE REGULATION OF MAPK CASCADE | 24 | 470 | 7.656e-07 | 5.591e-05 |
63 | CELL MOTILITY | 34 | 835 | 7.69e-07 | 5.591e-05 |
64 | LOCALIZATION OF CELL | 34 | 835 | 7.69e-07 | 5.591e-05 |
65 | CARTILAGE DEVELOPMENT | 13 | 147 | 7.998e-07 | 5.726e-05 |
66 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 37 | 957 | 8.45e-07 | 5.928e-05 |
67 | TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 31 | 724 | 8.536e-07 | 5.928e-05 |
68 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 22 | 408 | 9.12e-07 | 6.24e-05 |
69 | REGULATION OF OSSIFICATION | 14 | 178 | 1.25e-06 | 8.427e-05 |
70 | ORGAN GROWTH | 9 | 68 | 1.427e-06 | 9.36e-05 |
71 | REGULATION OF CHEMOTAXIS | 14 | 180 | 1.428e-06 | 9.36e-05 |
72 | CELLULAR RESPONSE TO EXTERNAL STIMULUS | 17 | 264 | 1.519e-06 | 9.819e-05 |
73 | EYE DEVELOPMENT | 19 | 326 | 1.644e-06 | 0.0001048 |
74 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 31 | 750 | 1.786e-06 | 0.0001123 |
75 | CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT | 9 | 70 | 1.831e-06 | 0.0001136 |
76 | ENDOTHELIUM DEVELOPMENT | 10 | 90 | 1.917e-06 | 0.0001173 |
77 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 34 | 872 | 2.02e-06 | 0.0001221 |
78 | TAXIS | 23 | 464 | 2.162e-06 | 0.000129 |
79 | ENDOTHELIAL CELL DIFFERENTIATION | 9 | 72 | 2.329e-06 | 0.0001372 |
80 | NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 11 | 115 | 2.629e-06 | 0.0001521 |
81 | MUSCLE TISSUE DEVELOPMENT | 17 | 275 | 2.648e-06 | 0.0001521 |
82 | POSITIVE REGULATION OF CELL DEVELOPMENT | 23 | 472 | 2.878e-06 | 0.0001633 |
83 | TUBE DEVELOPMENT | 25 | 552 | 3.885e-06 | 0.0002178 |
84 | RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE | 5 | 16 | 4.02e-06 | 0.0002201 |
85 | POSITIVE REGULATION OF CHEMOTAXIS | 11 | 120 | 3.992e-06 | 0.0002201 |
86 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 17 | 285 | 4.28e-06 | 0.0002315 |
87 | EPITHELIUM DEVELOPMENT | 35 | 945 | 4.443e-06 | 0.0002376 |
88 | HEAD DEVELOPMENT | 29 | 709 | 4.786e-06 | 0.000253 |
89 | REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 10 | 100 | 5.03e-06 | 0.000263 |
90 | CHONDROCYTE DIFFERENTIATION | 8 | 60 | 5.232e-06 | 0.0002675 |
91 | REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION | 8 | 60 | 5.232e-06 | 0.0002675 |
92 | REGULATION OF CELL DEATH | 47 | 1472 | 5.522e-06 | 0.0002793 |
93 | NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 10 | 102 | 6.017e-06 | 0.000301 |
94 | EPITHELIAL CELL DIFFERENTIATION | 23 | 495 | 6.307e-06 | 0.0003122 |
95 | POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 10 | 103 | 6.569e-06 | 0.0003184 |
96 | NEURON PROJECTION GUIDANCE | 14 | 205 | 6.556e-06 | 0.0003184 |
97 | DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 10 | 104 | 7.166e-06 | 0.0003402 |
98 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 26 | 609 | 7.139e-06 | 0.0003402 |
99 | REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 12 | 153 | 7.424e-06 | 0.0003489 |
100 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 28 | 689 | 7.918e-06 | 0.0003684 |
101 | UROGENITAL SYSTEM DEVELOPMENT | 17 | 299 | 8.076e-06 | 0.0003721 |
102 | POSITIVE REGULATION OF OSSIFICATION | 9 | 84 | 8.504e-06 | 0.0003879 |
103 | POSITIVE REGULATION OF CELL PROLIFERATION | 31 | 814 | 9.358e-06 | 0.0004227 |
104 | NEURON PROJECTION MORPHOGENESIS | 20 | 402 | 9.539e-06 | 0.0004227 |
105 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 19 | 368 | 9.488e-06 | 0.0004227 |
106 | PROTEIN PHOSPHORYLATION | 34 | 944 | 1.106e-05 | 0.000481 |
107 | EMBRYONIC ORGAN DEVELOPMENT | 20 | 406 | 1.102e-05 | 0.000481 |
108 | POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION | 7 | 48 | 1.12e-05 | 0.0004826 |
109 | TISSUE REMODELING | 9 | 87 | 1.136e-05 | 0.0004848 |
110 | EMBRYONIC ORGAN MORPHOGENESIS | 16 | 279 | 1.34e-05 | 0.000567 |
111 | CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 12 | 166 | 1.698e-05 | 0.000706 |
112 | INFLAMMATORY RESPONSE | 21 | 454 | 1.715e-05 | 0.000706 |
113 | NEGATIVE REGULATION OF CELL ADHESION | 14 | 223 | 1.705e-05 | 0.000706 |
114 | RESPONSE TO EXTERNAL STIMULUS | 53 | 1821 | 1.824e-05 | 0.0007445 |
115 | ACTIVIN RECEPTOR SIGNALING PATHWAY | 5 | 22 | 2.238e-05 | 0.0009055 |
116 | EMBRYO DEVELOPMENT | 32 | 894 | 2.298e-05 | 0.0009216 |
117 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 38 | 1152 | 2.366e-05 | 0.0009411 |
118 | EMBRYONIC MORPHOGENESIS | 23 | 539 | 2.457e-05 | 0.0009689 |
119 | NEGATIVE REGULATION OF LOCOMOTION | 15 | 263 | 2.655e-05 | 0.001038 |
120 | POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 16 | 296 | 2.769e-05 | 0.001074 |
121 | NEURON PROJECTION DEVELOPMENT | 23 | 545 | 2.919e-05 | 0.001123 |
122 | REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 9 | 99 | 3.236e-05 | 0.001224 |
123 | REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 9 | 99 | 3.236e-05 | 0.001224 |
124 | POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 9 | 100 | 3.507e-05 | 0.001316 |
125 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 16 | 303 | 3.672e-05 | 0.001367 |
126 | EXTRACELLULAR STRUCTURE ORGANIZATION | 16 | 304 | 3.82e-05 | 0.001411 |
127 | NEGATIVE REGULATION OF WOUND HEALING | 7 | 58 | 3.984e-05 | 0.00146 |
128 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 16 | 306 | 4.133e-05 | 0.001502 |
129 | PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION | 4 | 13 | 4.255e-05 | 0.001523 |
130 | PHOSPHORYLATION | 39 | 1228 | 4.237e-05 | 0.001523 |
131 | BONE DEVELOPMENT | 11 | 156 | 4.783e-05 | 0.001699 |
132 | DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 24 | 602 | 4.846e-05 | 0.001708 |
133 | POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 7 | 60 | 4.978e-05 | 0.001729 |
134 | POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 7 | 60 | 4.978e-05 | 0.001729 |
135 | REGULATION OF ACTIN FILAMENT BASED PROCESS | 16 | 312 | 5.21e-05 | 0.001796 |
136 | RETINA DEVELOPMENT IN CAMERA TYPE EYE | 10 | 131 | 5.397e-05 | 0.001846 |
137 | POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 7 | 62 | 6.167e-05 | 0.002095 |
138 | TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 12 | 190 | 6.415e-05 | 0.002163 |
139 | NEURON MIGRATION | 9 | 110 | 7.436e-05 | 0.002479 |
140 | DEVELOPMENTAL MATURATION | 12 | 193 | 7.459e-05 | 0.002479 |
141 | NEGATIVE REGULATION OF GENE EXPRESSION | 44 | 1493 | 7.728e-05 | 0.002532 |
142 | HEART DEVELOPMENT | 20 | 466 | 7.71e-05 | 0.002532 |
143 | REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 10 | 138 | 8.377e-05 | 0.002726 |
144 | MUSCLE STRUCTURE DEVELOPMENT | 19 | 432 | 8.449e-05 | 0.00273 |
145 | REGULATION OF OSTEOBLAST DIFFERENTIATION | 9 | 112 | 8.555e-05 | 0.002745 |
146 | OVULATION CYCLE PROCESS | 8 | 88 | 8.889e-05 | 0.002833 |
147 | NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 7 | 66 | 9.243e-05 | 0.002867 |
148 | REGULATION OF CHONDROCYTE DIFFERENTIATION | 6 | 46 | 9.208e-05 | 0.002867 |
149 | NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 7 | 66 | 9.243e-05 | 0.002867 |
150 | TELENCEPHALON DEVELOPMENT | 13 | 228 | 9.129e-05 | 0.002867 |
151 | REGULATION OF AXONOGENESIS | 11 | 168 | 9.353e-05 | 0.002882 |
152 | CARDIAC MUSCLE TISSUE DEVELOPMENT | 10 | 140 | 9.449e-05 | 0.002893 |
153 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 19 | 437 | 9.822e-05 | 0.002968 |
154 | REGULATION OF ENDOTHELIAL CELL MIGRATION | 9 | 114 | 9.812e-05 | 0.002968 |
155 | REGULATION OF CELL MORPHOGENESIS | 22 | 552 | 0.0001006 | 0.003019 |
156 | POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 5 | 30 | 0.0001089 | 0.003249 |
157 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 41 | 1381 | 0.0001184 | 0.003509 |
158 | RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 10 | 144 | 0.0001195 | 0.003518 |
159 | REPRODUCTIVE SYSTEM DEVELOPMENT | 18 | 408 | 0.0001246 | 0.003646 |
160 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 16 | 337 | 0.0001283 | 0.00373 |
161 | REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 6 | 49 | 0.000132 | 0.003815 |
162 | CELLULAR RESPONSE TO ACID CHEMICAL | 11 | 175 | 0.0001345 | 0.003862 |
163 | NEURON DEVELOPMENT | 25 | 687 | 0.0001436 | 0.004099 |
164 | SENSORY ORGAN MORPHOGENESIS | 13 | 239 | 0.0001462 | 0.004148 |
165 | NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 9 | 121 | 0.000155 | 0.004371 |
166 | REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 8 | 98 | 0.0001894 | 0.005308 |
167 | CELLULAR RESPONSE TO AMINO ACID STIMULUS | 6 | 53 | 0.0002053 | 0.00572 |
168 | CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 19 | 465 | 0.000218 | 0.006038 |
169 | REGULATION OF SYSTEM PROCESS | 20 | 507 | 0.0002373 | 0.006532 |
170 | REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 30 | 926 | 0.0002428 | 0.006646 |
171 | FOREBRAIN DEVELOPMENT | 16 | 357 | 0.0002466 | 0.006711 |
172 | TUBE MORPHOGENESIS | 15 | 323 | 0.0002629 | 0.007111 |
173 | REGULATION OF GROWTH | 23 | 633 | 0.0002704 | 0.007273 |
174 | RESPONSE TO GROWTH FACTOR | 19 | 475 | 0.0002847 | 0.007614 |
175 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 52 | 1977 | 0.0002939 | 0.007814 |
176 | MORPHOGENESIS OF AN EPITHELIUM | 17 | 400 | 0.0002959 | 0.007824 |
177 | MAINTENANCE OF CELL NUMBER | 9 | 132 | 0.0002983 | 0.007842 |
178 | CELL CHEMOTAXIS | 10 | 162 | 0.0003118 | 0.008106 |
179 | CELLULAR RESPONSE TO MECHANICAL STIMULUS | 7 | 80 | 0.000311 | 0.008106 |
180 | CHONDROCYTE DEVELOPMENT | 4 | 21 | 0.0003216 | 0.008314 |
181 | BIOLOGICAL ADHESION | 32 | 1032 | 0.0003271 | 0.008408 |
182 | SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION | 17 | 404 | 0.0003319 | 0.008485 |
183 | POSITIVE REGULATION OF KINASE ACTIVITY | 19 | 482 | 0.0003415 | 0.008588 |
184 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 48 | 1791 | 0.0003397 | 0.008588 |
185 | CELL FATE COMMITMENT | 12 | 227 | 0.0003391 | 0.008588 |
186 | CELL PROJECTION ORGANIZATION | 29 | 902 | 0.0003496 | 0.008747 |
187 | RESPONSE TO NITROGEN COMPOUND | 28 | 859 | 0.0003557 | 0.008852 |
188 | RHYTHMIC PROCESS | 14 | 298 | 0.0003729 | 0.009228 |
189 | REGULATION OF KINASE ACTIVITY | 26 | 776 | 0.0003827 | 0.009406 |
190 | POSITIVE REGULATION OF MUSCLE HYPERTROPHY | 4 | 22 | 0.0003881 | 0.009406 |
191 | SOMATIC STEM CELL DIVISION | 4 | 22 | 0.0003881 | 0.009406 |
192 | POSITIVE REGULATION OF CARDIAC MUSCLE HYPERTROPHY | 4 | 22 | 0.0003881 | 0.009406 |
193 | SEX DIFFERENTIATION | 13 | 266 | 0.0004131 | 0.009907 |
194 | POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 12 | 232 | 0.0004128 | 0.009907 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CYTOKINE BINDING | 13 | 92 | 2.841e-09 | 2.639e-06 |
2 | TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 12 | 81 | 6.705e-09 | 3.115e-06 |
3 | GROWTH FACTOR BINDING | 14 | 123 | 1.229e-08 | 3.806e-06 |
4 | TRANSFORMING GROWTH FACTOR BETA BINDING | 6 | 16 | 1.184e-07 | 2.749e-05 |
5 | TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY | 6 | 17 | 1.805e-07 | 3.353e-05 |
6 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 20 | 315 | 2.254e-07 | 3.49e-05 |
7 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 29 | 629 | 4.423e-07 | 5.136e-05 |
8 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 20 | 328 | 4.292e-07 | 5.136e-05 |
9 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 16 | 226 | 8.945e-07 | 9.233e-05 |
10 | PROTEIN KINASE ACTIVITY | 28 | 640 | 1.964e-06 | 0.0001824 |
11 | CORE PROMOTER PROXIMAL REGION DNA BINDING | 20 | 371 | 2.89e-06 | 0.000244 |
12 | RECEPTOR BINDING | 47 | 1476 | 5.934e-06 | 0.0004594 |
13 | KINASE ACTIVITY | 31 | 842 | 1.81e-05 | 0.001201 |
14 | RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY | 9 | 92 | 1.793e-05 | 0.001201 |
15 | SMAD BINDING | 8 | 72 | 2.069e-05 | 0.001282 |
16 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 39 | 1199 | 2.506e-05 | 0.001455 |
17 | REGULATORY REGION NUCLEIC ACID BINDING | 30 | 818 | 2.67e-05 | 0.001459 |
18 | CYTOKINE RECEPTOR BINDING | 15 | 271 | 3.752e-05 | 0.001937 |
19 | PROTEIN SERINE THREONINE KINASE ACTIVITY | 20 | 445 | 4.08e-05 | 0.001995 |
20 | RECEPTOR SIGNALING PROTEIN ACTIVITY | 11 | 172 | 0.0001154 | 0.005358 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | NEURON PROJECTION | 41 | 942 | 7.889e-09 | 4.607e-06 |
2 | CELL SURFACE | 34 | 757 | 7.915e-08 | 2.311e-05 |
3 | EXCITATORY SYNAPSE | 14 | 197 | 4.137e-06 | 0.0005477 |
4 | NEURON PART | 43 | 1265 | 3.072e-06 | 0.0005477 |
5 | INTRINSIC COMPONENT OF PLASMA MEMBRANE | 51 | 1649 | 5.135e-06 | 0.0005477 |
6 | SYNAPSE | 30 | 754 | 5.627e-06 | 0.0005477 |
7 | SOMATODENDRITIC COMPARTMENT | 27 | 650 | 7.8e-06 | 0.0006507 |
8 | CELL PROJECTION | 53 | 1786 | 1.063e-05 | 0.000776 |
9 | AXON | 19 | 418 | 5.463e-05 | 0.003545 |
10 | CELL JUNCTION | 36 | 1151 | 0.0001156 | 0.006749 |
11 | SITE OF POLARIZED GROWTH | 10 | 149 | 0.0001583 | 0.008404 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | hsa04390_Hippo_signaling_pathway | 12 | 154 | 7.936e-06 | 0.001429 | |
2 | hsa04151_PI3K_AKT_signaling_pathway | 17 | 351 | 6.216e-05 | 0.005595 | |
3 | hsa04115_p53_signaling_pathway | 7 | 69 | 0.0001229 | 0.007372 | |
4 | hsa04350_TGF.beta_signaling_pathway | 7 | 85 | 0.0004512 | 0.0203 | |
5 | hsa04380_Osteoclast_differentiation | 8 | 128 | 0.001135 | 0.04085 | |
6 | hsa04114_Oocyte_meiosis | 7 | 114 | 0.002531 | 0.07594 | |
7 | hsa04360_Axon_guidance | 7 | 130 | 0.005229 | 0.1205 | |
8 | hsa04510_Focal_adhesion | 9 | 200 | 0.005354 | 0.1205 | |
9 | hsa04010_MAPK_signaling_pathway | 10 | 268 | 0.01214 | 0.2193 | |
10 | hsa04512_ECM.receptor_interaction | 5 | 85 | 0.01221 | 0.2193 | |
11 | hsa04914_Progesterone.mediated_oocyte_maturation | 5 | 87 | 0.0134 | 0.2193 | |
12 | hsa04540_Gap_junction | 5 | 90 | 0.01534 | 0.2301 | |
13 | hsa04144_Endocytosis | 8 | 203 | 0.01764 | 0.2443 | |
14 | hsa04916_Melanogenesis | 5 | 101 | 0.024 | 0.3085 | |
15 | hsa04310_Wnt_signaling_pathway | 6 | 151 | 0.03615 | 0.4338 | |
16 | hsa04142_Lysosome | 5 | 121 | 0.04665 | 0.5248 | |
17 | hsa04640_Hematopoietic_cell_lineage | 4 | 88 | 0.05426 | 0.5745 | |
18 | hsa04810_Regulation_of_actin_cytoskeleton | 7 | 214 | 0.0594 | 0.5859 | |
19 | hsa04340_Hedgehog_signaling_pathway | 3 | 56 | 0.06184 | 0.5859 | |
20 | hsa04020_Calcium_signaling_pathway | 6 | 177 | 0.06788 | 0.6109 | |
21 | hsa00512_Mucin_type_O.Glycan_biosynthesis | 2 | 30 | 0.08415 | 0.7213 | |
22 | hsa04610_Complement_and_coagulation_cascades | 3 | 69 | 0.1007 | 0.7692 | |
23 | hsa04720_Long.term_potentiation | 3 | 70 | 0.104 | 0.7692 | |
24 | hsa04730_Long.term_depression | 3 | 70 | 0.104 | 0.7692 | |
25 | hsa04630_Jak.STAT_signaling_pathway | 5 | 155 | 0.1068 | 0.7692 | |
26 | hsa04520_Adherens_junction | 3 | 73 | 0.1142 | 0.7907 | |
27 | hsa04270_Vascular_smooth_muscle_contraction | 4 | 116 | 0.1187 | 0.7912 | |
28 | hsa04722_Neurotrophin_signaling_pathway | 4 | 127 | 0.1502 | 0.9655 | |
29 | hsa04530_Tight_junction | 4 | 133 | 0.1686 | 0.9813 | |
30 | hsa04210_Apoptosis | 3 | 89 | 0.1741 | 0.9813 | |
31 | hsa04970_Salivary_secretion | 3 | 89 | 0.1741 | 0.9813 | |
32 | hsa04514_Cell_adhesion_molecules_.CAMs. | 4 | 136 | 0.1781 | 0.9813 | |
33 | hsa04014_Ras_signaling_pathway | 6 | 236 | 0.1836 | 0.9813 | |
34 | hsa04672_Intestinal_immune_network_for_IgA_production | 2 | 49 | 0.1874 | 0.9813 | |
35 | hsa04150_mTOR_signaling_pathway | 2 | 52 | 0.205 | 1 | |
36 | hsa04670_Leukocyte_transendothelial_migration | 3 | 117 | 0.2931 | 1 | |
37 | hsa04622_RIG.I.like_receptor_signaling_pathway | 2 | 71 | 0.3185 | 1 | |
38 | hsa04976_Bile_secretion | 2 | 71 | 0.3185 | 1 | |
39 | hsa04971_Gastric_acid_secretion | 2 | 74 | 0.3363 | 1 | |
40 | hsa04110_Cell_cycle | 3 | 128 | 0.3417 | 1 | |
41 | hsa04070_Phosphatidylinositol_signaling_system | 2 | 78 | 0.3598 | 1 | |
42 | hsa04062_Chemokine_signaling_pathway | 4 | 189 | 0.3646 | 1 | |
43 | hsa04974_Protein_digestion_and_absorption | 2 | 81 | 0.3772 | 1 | |
44 | hsa04666_Fc_gamma_R.mediated_phagocytosis | 2 | 95 | 0.4554 | 1 | |
45 | hsa04912_GnRH_signaling_pathway | 2 | 101 | 0.4872 | 1 | |
46 | hsa04972_Pancreatic_secretion | 2 | 101 | 0.4872 | 1 | |
47 | hsa04620_Toll.like_receptor_signaling_pathway | 2 | 102 | 0.4924 | 1 | |
48 | hsa04910_Insulin_signaling_pathway | 2 | 138 | 0.6558 | 1 | |
49 | hsa04120_Ubiquitin_mediated_proteolysis | 2 | 139 | 0.6597 | 1 | |
50 | hsa00230_Purine_metabolism | 2 | 162 | 0.7395 | 1 |